Table 2

CV event-related costs by cohort and index event

CohortGroupnTotal costs (in £)Incremental total costs (in £)
Baseline (1 year before first CV event) (mean (SE))Months 1–6 (mean (SE))Months 7–36 annualised (mean (SE))Months 1–6 (mean (SE))Months 7–36 annualised (mean (SE))
First eventMyocardial infarction44682266.34 (163.45)5297.59 (115.51)2350.66 (165.54)4275.41 (102.41)922.43 (155.58)
Unstable angina58011965.61 (86.76)3133.12 (61.44)2081.84 (65.15)2179.24 (48.51)328.45 (61)
Ischaemic stroke34891962.42 (119.73)4389.27 (102.29)2526.63 (276.42)3512.25 (102.82)972.62 (257.48)
PTCA/CABG*50822412.2 (95.69)6843.38 (94.67)1855.11 (110.02)5635.19 (87.29)−368.26 (103.58)
Heart failure35963148.72 (136.77)3988.86 (111.87)3607.86 (313.16)2443.58 (95.22)847.55 (247.64)
Transient ischaemic attack16572109.76 (215.46)2488.83 (89.42)2362.10 (152.91)1536.88 (69.22)704.76 (147.47)
All patients (hospital)24 0931565.41 (56.72)4059.91 (38.39)1432.92 (59.15)3337.51 (37.75)203.18 (48.2)
All patients (total)24 0932301.34 (57.26)4594.16 (39.01)2262.92 (60.37)3504.01 (38.04)361.11 (48.79)
Second eventMyocardial infarction7692611.88 (326.29)5785.47 (353.52)3887.74 (909.42)4301.01 (330.02)1384.51 (622.14)
Unstable angina13472795.44 (398.16)3925.66 (204.31)2844.49 (247.33)2489.48 (132.63)676.82 (278.78)
Ischaemic stroke5322202.96 (143.98)5607.47 (273.97)2870.35 (281.51)4572.28 (280.27)682.29 (438.78)
PTCA/CABG*12561635.76 (63.68)6630.29 (208.77)2121.06 (302.87)5823.12 (202.55)598.64 (296.25)
Heart failure11042737.60 (97.24)4818.24 (318.44)5554.17 (1732.62)3460.91 (312.14)2829.02 (1643.39)
Transient ischaemic attack2661999.77 (142.44)2734.81 (183.68)3337.07 (814.53)1813.63 (187.64)1691.81 (790.76)
All patients (hospital)52741588.26 (100.82)4530.08 (100.6)2061.65 (237.53)3736.68 (85.06)762.21 (237.68)
All patients (total)52742380.42 (100.97)5147.79 (100.62)2998.11 (242.14)3967.74 (84.73)1017.68 (239.47)
First and second events combinedMyocardial infarction52372317.12 (144.72)5354.01 (113.64)2472.28 (168.56)4277.23 (95.51)958.78 (134.53)
Unstable angina71482121.98 (111.68)3261.27 (65.83)2179.64 (75.16)2229.42 (50.81)373.15 (74.47)
Ischaemic stroke40211994.31 (91.59)4533.08 (103.14)2545.1 (274.62)3637.86 (103.05)953.48 (261.93)
PTCA/CABG*63382258.28 (69.8)6802.98 (86.73)1894.5 (89.56)5669.47 (85.13)−220.73 (83.14)
Heart failure47003052.04 (112.99)4144.89 (116.03)3881.8 (344.1)2635.35 (105.35)1128.86 (300.08)
Transient ischaemic attack19232094.55 (195.16)2519.75 (87.9)2447.92 (150.36)1571.55 (68.74)792.85 (146.55)
All patients (hospital)29 3671569.51 (43.75)4133.76 (40.95)1508.48 (59.3)3400.25 (35.58)269.32 (53.9)
All patients (total)29 3672315.55 (43.78)4681.04 (41.45)2351.28 (59.09)3576.82 (36.18)438.89 (54)
  • *The proportions of revascularisation events that were CABG were 42% (2137/5082), 35% (442/1256) and 41% (2579/6338) for the first event, second event and all (combined) cohorts, respectively.

  • CABG, coronary artery bypass graft; CV, cardiovascular; PTCA, percutaneous transluminal coronary angioplasty.